Neurocrine Biosciences Inc. (NBIX)
Market Closed
17 Jul, 20:00
$
170. 88
-0.67
-0.3906%
$
17.3B Market Cap
63.27 P/E Ratio
- Div Yield
929,700 Volume
2.29 Eps
$ 171.55
Previous Close 
Want to track NBIX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neurocrine Biosciences Inc. (NBIX) Statistics
Valuation metrics
Market Cap 17.3B
Enterprise value 17.32B
Trailing P/E (ttm) 25.47
Forward P/E 9.91
PEG ratio 0.21
Price/Sales (ttm) 5.54
Price/Book (mrq) 5.04
Enterprise Value/Revenue 5.58
Enterprise Value/EBITDA 18.12
Overview
Shares outstanding 100.1M
Float 99.08M
Shares short 5.64M
% Held by insiders 0.01%
% Held by institutions 1.01%
Average volume (10 days) 905.57K
Average volume (90 days) 1.19M
Price summary
52-Week low 122.14
52-Week high 181.18
Beta 0.35
50-Day moving average 165.69
200-Day moving average 138.79
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.22%
Operating margin 0.25%
Operational effectiveness
Return on assets 0.14%
Return on equity 0.22%
Income Statement
Revenue (ttm) 2.86B
Revenue per share (ttm) 30.87
Quarterly revenue growth (yoy) 0.28%
Gross profit (ttm) 1.79B
EBITDA 688M
Net income to common (ttm) 478.6M
Diluted EPS (ttm) 6.65
Quarterly earnings growth (yoy) 0.49%
Balance Sheet
Total cash (mrq) 1.48B
Total cash per share (mrq) 13.1
Total debt (mrq) 471.3M
Total Debt/Equity (mrq) 0.12
Current ratio (mrq) 2.93%
Book value per share (mrq) 33.9
Cash Flow
Cash flow statement 782.7M
Levered free cash flow (LFCF) 397.81M
